SARS-CoV-2 Infection in Health Workers: Analysis from Verona SIEROEPID Study during the Pre-Vaccination Era

Stefano Porru, Maria Grazia Lourdes Monaco, Angela Carta, Gianluca Spiteri, Marco Parpaiola, Andrea Battaggia, Giulia Galligioni, Beatrice Ferrazzi, Giuliana Lo Cascio, Davide Gibellini, Angelo Peretti, Martina Brutti, Stefano Tardivo, Giovanna Ghirlanda, Giuseppe Verlato, Stefania Gaino, Denise Peserico, Antonella Bassi and Giuseppe Lippi
Additional contact information
Stefano Porru: Section of Occupational Medicine, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy
Maria Grazia Lourdes Monaco: Clinical Unit of Occupational Medicine, University Hospital of Verona, 37134 Verona, Italy
Angela Carta: Section of Occupational Medicine, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy
Gianluca Spiteri: Clinical Unit of Occupational Medicine, University Hospital of Verona, 37134 Verona, Italy
Marco Parpaiola: Postgraduate School of Occupational Medicine, University of Verona, 37134 Verona, Italy
Andrea Battaggia: Postgraduate School of Occupational Medicine, University of Verona, 37134 Verona, Italy
Giulia Galligioni: Postgraduate School of Occupational Medicine, University of Verona, 37134 Verona, Italy
Beatrice Ferrazzi: Postgraduate School of Occupational Medicine, University of Verona, 37134 Verona, Italy
Giuliana Lo Cascio: Local Heath Authority of Piacenza, 29121 Piacenza, Italy
Davide Gibellini: Section of Microbiology, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy
Angelo Peretti: Unit of Microbiology and Virology, University Hospital of Verona, 37134 Verona, Italy
Martina Brutti: Unit of Microbiology and Virology, University Hospital of Verona, 37134 Verona, Italy
Stefano Tardivo: Section of Hygiene, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy
Giovanna Ghirlanda: Medical Direction, University Hospital of Verona, 37134 Verona, Italy
Giuseppe Verlato: Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy
Stefania Gaino: Laboratory of Clinical Chemistry and Hematology, University Hospital of Verona, 37134 Verona, Italy
Denise Peserico: Section of Clinical Biochemistry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy
Antonella Bassi: Laboratory of Clinical Chemistry and Hematology, University Hospital of Verona, 37134 Verona, Italy
Giuseppe Lippi: Laboratory of Clinical Chemistry and Hematology, University Hospital of Verona, 37134 Verona, Italy

IJERPH, 2021, vol. 18, issue 12, 1-11

Abstract: Background: To report the baseline phase of the SIEROEPID study on SARS-CoV-2 infection seroprevalence among health workers at the University Hospital of Verona, Italy, between spring and fall 2020; to compare performances of several laboratory tests for SARS-CoV-2 antibody detection. Methods: 5299 voluntary health workers were enrolled from 28 April 2020 to 28 July 2020 to assess immunological response to SARS-CoV-2 infection throughout IgM, IgG and IgA serum levels titration by four laboratory tests. Association of antibody titre with several demographic variables, swab tests and performance tests (sensitivity, specificity, and agreement) were statistically analyzed. Results: The overall seroprevalence was 6%, considering either IgG and IgM, and 4.8% considering IgG. Working in COVID-19 Units was not associated with a statistically significant increase in the number of infected workers. Cohen’s kappa of agreement between MaglumiTM and VivaDiagTM was quite good when considering IgG only (Cohen’s kappa = 78.1%, 95% CI 74.0–82.0%), but was lower considering IgM (Cohen’s kappa = 13.3%, 95% CI 7.8–18.7%). Conclusion: The large sample size with high participation (84.7%), the biobank and the longitudinal design were significant achievements, offering a baseline dataset as the benchmark for risk assessment, health surveillance and management of SARS-CoV-2 infection for the hospital workforce, especially considering the ongoing vaccination campaign. Study results support the national regulator guidelines on using swabs for SARS-CoV-2 screening with health workers and using the serological tests to contribute to the epidemiological assessment of the spread of the virus.

Keywords: SARS-CoV-2 infection; serosurvey; health workers (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/12/6446/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/12/6446/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:12:p:6446-:d:574884

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().